Alnara Therapeutics Raises $35 Million
Alnara Therapeutics Inc., a Cambridge, Mass.-based developer of orally-delivered protein therapeutics for the treatment of metabolic diseases, has raised $35 million in Series B funding. MPM Capital led the round, and was joined by return backers Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. The company previously raised $20 million.
28 January 2010•4 mins read
